Biolase Inc (NASDAQ:BIOL) Stock Resumes Uptrend After The Recent Consolidation

Biolase Inc (NASDAQ:BIOL), which is one of the worldwide leaders in the field of dental lasers, has not been in the news for some days but that did not stop its stock from delivering considerable gains yesterday. Investors seemed to have taken a shine to the Biolase stock yesterday and consequently it ended the day with gains of as much as 15%.

In light of such gains, it could be useful for investors to perhaps take a look at the company’s financial results for the second fiscal quarter that ended on June 30, 2021. The results were announced on August 12.

The company managed to bring in revenues to the tune of as much as $9.1 million in the second quarter and that reflected a year on year rise of a staggering 211%. In this regard, it should also be noted that as much as 70% of the total sales in the United States generated by Biolase was generated through new customers and that was actually the continuation of a trend that had set in before. On the other hand, the laser systems sales clocked a year on year rise of as much as 424%. It could be the right time to put the Biolase stock in your watch lists.